ARDS
Aridis Pharmaceuticals Inc. Common Stock
ARDS
ARDS
Delisted
ARDS was delisted on the 18th of July, 2023.
5 hedge funds and large institutions have $642K invested in Aridis Pharmaceuticals Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$502K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$118K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$19K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $502K | 45,665 | +45,665 | New |
|
|
2
Millennium Management
New York
| $118K | 10,763 | -1,349 | -11% |
|
|
3
UBS Group
Zurich,
Switzerland
| $19K | 1,651 | -375 | -19% |
|
4
Wells Fargo
San Francisco,
California
| $3K | 300 | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | – | -158 | Closed |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
MWNA
7
Marshall Wace North America
New York
| $0 | 19 | +19 | New |
|